Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ADEMPAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ADEMPAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

ADEMPAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Bayer Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 9, 2023
Approval ID: 5aa62b29bdcdfa1d
Company: Bayer Ag
Type: Standard

Approval Details

Approval Id: 5aa62b29bdcdfa1d
Drug Cima Aemps Name: ADEMPAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 113907004IP
Holder Company Name: Bayer Ag
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/bayer-ag
Authorization Date: 2023-02-09
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 1 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Bayer Ag
Company Detail Path: /organization/bayer-ag

Company Information

Pharmaceutical Company Name: BAYER AG
Name En: Bayer AG
Country Name: Germany
City Name: Leverkusen
Address: Leverkusen, North Rhine-Westphalia, Germany
Website: https://www.bayer.com

Active Ingredients

RIOCIGUAT

1 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2023

Approval ID

5aa62b29bdcdfa1d

Type

Standard

Back to CIMA-AEMPS Approvals